| abstract |
The invention relates to insulin resistance, Gaucher disease, inflammatory disease, hyperpigmentation and / or inflammatory conditions of the skin, overweight and obesity, lysosomal storage disorders, mycosis, melanoma and other tumors, and microbacterial infections A new class of deoxynojirimycin analogues or pharmaceutically acceptable salts thereof can be provided that can be suitably used for the treatment of diseases selected from the group consisting of microbacterial infections. The present invention further provides a pharmaceutical composition comprising the deoxynojirimycin analog or a pharmaceutically acceptable salt thereof and a pharmaceutically acceptable carrier. |